The Food and Drug Administration has approved Journavx (suzetrigine) for the treatment of moderate to severe acute pain in adults.
The encouraging result comes just days after the US FDA approved Vertex Pharma's non-opioid painkiller Journavx (suzetrigine) ...
Allosteric GABAA-receptor modulator AP-325 showed rapid onset as well as long-lasting pain reduction in patients with chronic neuropathic pain in Phase 2a study Data confirm previously reported ...
The Hearthstone ranked system consists of five tiers (Bronze to Diamond) and a Legend rank, determined by hidden MMR.
Algiax Pharmaceuticals, a clinical-stage biotech company focused on developing innovative treatments for chronic neuropathic pain, today announced compelling topline data from its Phase 2a clinical ...
Researchers have explored how integrating machine and deep learning techniques can create a standardized system for evaluating rock climbing routes to provide a difficulty grading scale that promotes ...
The Golden State Warriors rode Andrew Wiggins (25 points) and Stephen Curry (24 points) to overcome the Orlando Magic 104-99 ...